1. Home
  2. GRNQ vs CRIS Comparison

GRNQ vs CRIS Comparison

Compare GRNQ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.78

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.50

Market Cap

20.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
CRIS
Founded
2013
2000
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
20.6M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
GRNQ
CRIS
Price
$1.78
$0.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
11.1K
212.3K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.57
EPS
N/A
N/A
Revenue
$3,673,997.00
$9,898,000.00
Revenue This Year
N/A
$27.10
Revenue Next Year
N/A
$67.74
P/E Ratio
N/A
N/A
Revenue Growth
24.55
31.50
52 Week Low
$1.10
$0.46
52 Week High
$3.18
$3.13

Technical Indicators

Market Signals
Indicator
GRNQ
CRIS
Relative Strength Index (RSI) 44.70 43.94
Support Level $1.63 $0.48
Resistance Level $1.88 $0.63
Average True Range (ATR) 0.11 0.04
MACD 0.04 0.01
Stochastic Oscillator 76.47 44.18

Price Performance

Historical Comparison
GRNQ
CRIS

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: